CL2021003592A1 - Compuestos y métodos de uso de los mismos como agentes antibacterianos. - Google Patents

Compuestos y métodos de uso de los mismos como agentes antibacterianos.

Info

Publication number
CL2021003592A1
CL2021003592A1 CL2021003592A CL2021003592A CL2021003592A1 CL 2021003592 A1 CL2021003592 A1 CL 2021003592A1 CL 2021003592 A CL2021003592 A CL 2021003592A CL 2021003592 A CL2021003592 A CL 2021003592A CL 2021003592 A1 CL2021003592 A1 CL 2021003592A1
Authority
CL
Chile
Prior art keywords
compounds
methods
antibacterial agents
trizol
treatment
Prior art date
Application number
CL2021003592A
Other languages
English (en)
Inventor
Philippe Nantermet
Brendan M Crowley
David Olsen
Takao Suzuki
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Publication of CL2021003592A1 publication Critical patent/CL2021003592A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPUESTOS HETEROCÍCLICOS DERIVADOS DE TRIZOL; COMPOSICIÓN FARMACÉUTICA; Y USO EN EL TRATAMIENTO DE UNA INFECCION BACTERIANA.
CL2021003592A 2019-07-03 2021-12-30 Compuestos y métodos de uso de los mismos como agentes antibacterianos. CL2021003592A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2019/094601 WO2021000297A1 (en) 2019-07-03 2019-07-03 Compounds and methods of use thereof as antibacterial agents

Publications (1)

Publication Number Publication Date
CL2021003592A1 true CL2021003592A1 (es) 2022-10-07

Family

ID=74100984

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2021003592A CL2021003592A1 (es) 2019-07-03 2021-12-30 Compuestos y métodos de uso de los mismos como agentes antibacterianos.

Country Status (20)

Country Link
US (1) US20220235041A1 (es)
EP (1) EP3997073A4 (es)
JP (1) JP7183455B2 (es)
KR (1) KR20220028015A (es)
CN (1) CN114341119A (es)
AU (1) AU2020300400B2 (es)
BR (1) BR112021026762B1 (es)
CA (1) CA3145555C (es)
CL (1) CL2021003592A1 (es)
CO (1) CO2021018154A2 (es)
CR (1) CR20220003A (es)
EA (1) EA202290215A1 (es)
EC (1) ECSP21093897A (es)
GE (1) GEP20247616B (es)
IL (1) IL289336A (es)
JO (1) JOP20210353A1 (es)
MX (1) MX2021015841A (es)
PE (1) PE20220903A1 (es)
WO (2) WO2021000297A1 (es)
ZA (1) ZA202110692B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4296674A1 (en) 2022-06-20 2023-12-27 Université Toulouse III - Paul Sabatier Innovative molecules decreasing virulence of mycobacterium for the treatment of tuberculosis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT920421E (pt) * 1996-08-21 2003-03-31 Upjohn Co Derivados de isoxazolina uteis como agentes antimicrobianos
EP1054874B1 (en) * 1998-02-13 2002-08-28 PHARMACIA & UPJOHN COMPANY Substituted aminophenyl isoxazoline derivatives useful as antimicrobials
JP2005512975A (ja) 2001-10-25 2005-05-12 アストラゼネカ アクチボラグ 抗菌薬として有用なイソキサゾリン誘導体
US7091196B2 (en) * 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
CN101220000B (zh) * 2007-12-28 2010-12-22 天津药物研究院 酰氯和磺酰氯类衍生物及其用途
WO2017066964A1 (en) 2015-10-22 2017-04-27 Merck Sharp & Dohme Corp. Oxazolidinone compounds and methods of use thereof as antibacterial agents

Also Published As

Publication number Publication date
JOP20210353A1 (ar) 2023-01-30
CO2021018154A2 (es) 2022-01-17
CA3145555A1 (en) 2021-01-07
GEP20247616B (en) 2024-03-25
CA3145555C (en) 2023-10-03
AU2020300400B2 (en) 2023-04-13
US20220235041A1 (en) 2022-07-28
JP7183455B2 (ja) 2022-12-05
CN114341119A (zh) 2022-04-12
WO2021000297A1 (en) 2021-01-07
BR112021026762A2 (pt) 2022-02-15
ZA202110692B (en) 2023-10-25
CR20220003A (es) 2022-02-08
EP3997073A1 (en) 2022-05-18
WO2021000684A1 (en) 2021-01-07
ECSP21093897A (es) 2022-01-31
BR112021026762A8 (pt) 2023-01-31
PE20220903A1 (es) 2022-05-30
AU2020300400A1 (en) 2022-01-27
EA202290215A1 (ru) 2022-03-25
IL289336A (en) 2022-02-01
EP3997073A4 (en) 2023-07-26
MX2021015841A (es) 2022-02-03
KR20220028015A (ko) 2022-03-08
BR112021026762B1 (pt) 2024-01-02
JP2022530709A (ja) 2022-06-30

Similar Documents

Publication Publication Date Title
CL2020000075A1 (es) Carboxamidas como moduladores de los canales de sodio.
CL2021003477A1 (es) Compuestos 2,3-dihidroquinazolin como inhibidores nav1 .8
CL2020003257A1 (es) Compuestos antagonistas de pcsk9.
CL2016000698A1 (es) Derivados de quinolizina sustituidos útiles como inhibidores de integrasa del vih
GT201500088A (es) Derivados de 5-fenoxi-3h-pirimidin-4-ona y su uso como inhibidores de la transcriptasa inversa del vih
CL2016002269A1 (es) Moduladores alostéricos del núcleo proteico de la hepatitis b.
CL2008003406A1 (es) Compuestos derivados de quinolina; composicion farmaceutica que los comprende; y uso en el tratamiento de una infeccion por vih.
CL2013002417A1 (es) Compuestos derivados de fluoropiridinona; composición farmacéutica que los comprende; y su uso en el tratamiento de infecciones bacterianas.
MX2021000189A (es) Compuestos heterociclicos que contienen bencilamina y composiciones utiles contra infeccion por micobacterias.
DOP2016000336A (es) Derivados de isoindolina para uso en el tratamiento de una infeccion viral
CL2015002755A1 (es) Composiciones antibióticas de ceftolozano.
DOP2012000256A (es) Inhibidores no nucleosídicos de la transcriptasa inversa
CL2016001524A1 (es) Derivados antibacterianos de 1h-indazol y 1h-indol.
BR112017026061A2 (pt) composto, uso de um composto, e, método de tratamento de uma infecção viral
NI201600149A (es) Cromeno y 1,1a,2,7b-tetrahidrociclopropa[c]cromeno piridopirazinadionas como moduladores de gamma-secretasa
CL2017001276A1 (es) Derivados de benzotiazol antibacterianos
CR20180091A (es) 5-(n-bencil-tetrahidroisoquinolin-6-il)-piridin-3-il acético como inhibidores de la replicación del vih
CL2017002451A1 (es) Compuestos heterocíclicos novedosos y su uso en la prevención o tratamiento de las infecciones bacterianas
ECSP18060820A (es) Derivados de 3-(carboxietil)-8-amino-2-oxo-1,3-diaza-espiro-[4.5]- decano
DOP2019000100A (es) Derivados de naftiridinona y su uso en el tratamiento de la arritmia
MX2019006768A (es) Peptidos antimicrobianos.
CO2021006480A2 (es) Inhibidores de rip1
CL2021003592A1 (es) Compuestos y métodos de uso de los mismos como agentes antibacterianos.
CL2022000522A1 (es) Lurbinectedina en el tratamiento del mesotelioma maligno.
CL2019000857A1 (es) Compuestos heterocíclicos y su uso para prevenir o tratar las infecciones bacterianas.